VivoSim Labs, INC. — Form 8-K
Filed July 17, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 53/100
What the filing says
VivoSim Labs issued approximately $4 million in securities comprising common stock, pre-funded warrants (exercise price $0.001/share), and common warrants (exercise price $0.85/share, 5-year term) to unidentified purchasers on July 16, 2026. The offering included an amendment to prior warrants held by Armistice Capital Master Fund reducing exercise price from $9.60 to $0.85 pending shareholder approval. A.G.P./Alliance Global Partners served as placement agent.
Why this rating
~$4M raise is 53% of company's $7.5M market cap—material for funding but common in microcaps; warrant repricing favorable to holders but dilutive if exercised; shareholder approval still pending.
See more from July 17, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.